Sachol

Quick links to important sections

Sachol

Selected form

Treatment option: Fever

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sachol

What is Sachol? (Quick Facts and Foundational Overview)

Property Description
Active Ingredients Choline Salicylate and Cetalkonium Chloride
Form Oral/Gingival Gel (Dental Gel)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) derivative and Antiseptic
General Purpose Symptomatic relief of oral discomfort and localized irritation
Origin Synthetic derivative (Choline Salicylate)

What Type of Medicine is Sachol and How is it Classified?

Sachol is a pharmaceutical combination product formulated as a topical oral anti-inflammatory and analgesic preparation intended for localized use on the mouth and gums. This medicine is classified pharmacologically as a blend of a Nonsteroidal Anti-inflammatory Drug (NSAID) derivative and an Antiseptic agent. The primary active component, Choline Salicylate, is a synthetic derivative of Salicylic Acid. The design, which utilizes a gel as the dosage form, is a key differentiating feature, enabling focused local action and adherence to the moist oral mucosa, a necessity for effective treatment of surface irritations.


The Active Components: Choline Salicylate and Cetalkonium Chloride

The preparation contains two distinct active ingredients: Choline Salicylate and Cetalkonium Chloride, which deliver its specific therapeutic profile. Choline Salicylate serves as the primary agent for localized pain relief and reducing the swelling and redness associated with inflammation. This component works to ease pain by actively reducing local inflammatory signals. Cetalkonium Chloride, a quaternary ammonium compound, is included specifically for its demonstrable antiseptic properties, which assist in maintaining local hygiene. The hydrophilic gel is specialized to facilitate effective retention of the active substances when applied to the oral mucosa and gingiva.


What is the General Therapeutic Purpose of Sachol Gel?

The general therapeutic purpose of Sachol gel is to provide comprehensive, rapid symptomatic relief from general oral discomfort resulting from irritation in the mouth and on the gums. By furnishing a mild analgesic and anti-inflammatory effect alongside a topical antiseptic action, the preparation serves to address both the pain sensation and the potential for localized microbial proliferation. This dual action of localized pain relief and disinfection is a critical feature for treating surface-level mucosal irritations. Its utility is confined to the immediate, symptomatic management of conditions where local irritation and inflammation are the predominant patient complaints.

What side effects are possible with Sachol?

Possible Side Effects and Safety Information

The safety profile for this topical oral gel containing Choline Salicylate and Cetalkonium Chloride is structured according to regulatory classifications, addressing both common localized effects and rare systemic risks associated with the salicylate component.


Adverse Reactions and Frequency

Adverse reactions that appear at the site of application, such as a local burning sensation or transient irritation, are frequently documented and generally considered expected or common effects for this type of product. Most potential systemic effects are classified as Not known due to the difficulty of estimating their frequency from available data following topical use.

Officially documented side effects fall primarily under the General disorders and administration site conditions and Immune system disorders System-Organ-Classes (SOC).


Serious Adverse Reaction Risk and Restrictions

Regulatory documents emphasize safety constraints related to the potential for systemic salicylate absorption. The official profile highlights the serious but rare theoretical risk of Reye's Syndrome associated with salicylate use in children and adolescents recovering from viral illnesses. This risk necessitates a contraindication for use in infants and often for children under 16 years of age in several jurisdictions.

Additionally, the gel is contraindicated in individuals with a known hypersensitivity to salicylates or active peptic ulceration. Safety notes explicitly caution against prolonged or excessive use, as this increases the potential for systemic adverse effects and localized mucosal damage, which may also enhance the effect of concurrent anticoagulant medicines.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of a product containing choline salicylate, the active ingredient in Sachol, may result in systemic salicylate toxicity, also known as salicylism.

Classification Symptoms and Required Actions
Documented Manifestations Symptoms of systemic poisoning may include tinnitus (ringing in the ears), hyperventilation (rapid, deep breathing), nausea, vomiting, confusion, and dizziness. Severe cases can involve fever, metabolic acidosis, and gastrointestinal bleeding.
Severe Outcomes Life-threatening consequences include seizures, altered mental status leading to coma, respiratory failure, and cerebral or pulmonary edema. Chronic, repeated exposures may be more serious than a single large dose.
Emergency Action Seek immediate medical attention for a suspected or known overdose, regardless of whether symptoms are present. Contact a local Poison Control Center or emergency medical services right away.

Management of toxicity typically focuses on supportive care, correcting fluid, electrolyte, and acid-base disturbances (like metabolic acidosis), and measures to enhance drug elimination, such as urinary alkalinization or, in severe cases, hemodialysis. The regulatory standard requires immediate emergency services to be contacted for all cases of suspected overdosage.

Therapeutic Uses of Sachol

What Sachol Treats: Main Uses and Benefits

Symptomatic Relief for Oral Lesions and Ulcers

The gel is commonly used in situations involving certain distressing symptoms and localized discomfort in the mouth. This preparation is considered relevant when supportive symptom management is appropriate for conditions presenting with acute or disruptive symptom patterns.

This domain covers symptomatic management of symptoms related to localized discomfort and soreness, such as those from common mouth ulcers (canker sores), gingivitis (inflamed gums), and stomatitis. The gel helps address symptom clusters that may appear suddenly, offering supportive relief relevant for easing periods of localized pain and burning. This therapeutic support contributes to improved comfort during periods of heightened symptoms.

Management in Functional Contexts

It is relevant in conditions characterized by periods of heightened symptoms and addresses symptomatic discomfort arising from mechanical or irritative sources, such as soreness caused by new or ill-fitting dentures and minor traumatic lesions. Applied in contexts where additional support for symptom management is needed, the product provides supportive relief when symptoms interfere with routine activities like eating or speaking.


Quick Fact: Relief for Localized Oral Discomfort
The product is commonly used to help with symptomatic relief for gingivitis, mouth ulcers, and soreness from dental appliances.

Regulatory References

  1. Summary of Product Characteristics (SmPC) from the HPRA

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Sachol

Sachol, a brand name for Choline Salicylate and Cetalkonium Chloride oral gel, has strict eligibility rules based on its regulatory label, primarily due to the salicylate component.

Populations for whom use is Contraindicated (Must Not Be Used)

Contraindicated Group Basis of Exclusion
Hypersensitivity Allergy to Choline Salicylate, Cetalkonium Chloride, other Salicylates (like aspirin), or any of the product’s excipients.
Age Restriction (Reye's Risk) Children under 16 years of age in some regulatory regions (e.g., UK/Ireland), especially if the child is recovering from a viral illness (influenza, chickenpox).
Infants Infants under 4 months of age.
Pre-existing Conditions Patients with active or a history of recurrent peptic ulceration.

Restricted or Conditional Use

  • Pregnancy: Not recommended during the third trimester. Consultation with a doctor is required for use during the first or second trimesters.
  • Breastfeeding: Although low quantities of salicylate enter breast milk, the label advises avoidance or to consult a healthcare professional. Short-term use at the recommended dose may not require suspending breastfeeding per some labels.
  • Other Medications: Use with Anticoagulants (blood thinners) or other Salicylates/Aspirin is restricted and should be avoided unless under medical direction due to enhanced effects.

Age-Related Eligibility

Adults and adolescents 16 years and older are generally eligible for use. Some international labels permit use for children from 4 months of age, but this use must strictly adhere to the stated dose to avoid the risk of salicylate poisoning.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sachol is a topical oromucosal gel containing Choline Salicylate, which is systemically absorbed, and Cetalkonium Chloride. The officially documented interaction profile is focused on the systemic effects of the salicylate component, similar to those seen with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).


Documented Interaction Categories

Category Description of Official Constraint
Combination Avoidance The product should generally not be used concurrently with other salicylates or NSAIDs to avoid cumulative toxicity and potential systemic adverse effects.
Anticoagulants Co-administration may enhance the effect of anticoagulants (e.g., Warfarin), leading to an increased risk of bleeding. Close monitoring is necessary.
Uricosuric Agents Salicylates may inhibit the action of uricosuric agents (e.g., Probenecid), reducing their therapeutic efficacy in managing gout.

Population and Procedural Constraints

There is a critical, interaction-related restriction for pediatric use: the product must not be used in children or adolescents under 16 years who are currently experiencing a viral illness (such as influenza or chickenpox). This constraint is due to the potential association between salicylates and Reye's syndrome in this context. Furthermore, for procedural reasons when treating denture irritation, a separation of 30 minutes is required after applying the gel before re-inserting dentures.

Mechanism of Action

How Sachol Works: Mechanistic Action

Sachol gel contains two active pharmacological components: choline salicylate and cetalkonium chloride. The overall pharmacological action is a result of the contributions from both constituents, focusing on cellular and biochemical processes within the applied area.

Choline Salicylate

The choline salicylate component, a salt of salicylic acid, exerts its primary mechanistic effect via the inhibition of cyclooxygenase (COX) enzyme activity. Specifically, it reduces the synthesis of prostaglandins from arachidonic acid within local cells. Prostaglandins function as lipid mediators in cell signaling, and their reduced synthesis results in the modulation of local inflammatory cascades and the attenuation of afferent pain impulse generation at peripheral nerve endings.

Cetalkonium Chloride

Cetalkonium chloride functions as a quaternary ammonium compound. Its mechanism is characterized by the disruption of cellular integrity. This compound possesses a positive charge, which allows it to interact with negatively charged components of cell membranes, particularly those of bacteria and fungi. This interaction results in the structural destabilization and permeabilization of the cell membrane, leading to the inactivation of essential intracellular enzymes and protein denaturation. This process modulates the local microbial environment.

Dosage and Administration Information

The following is a summary of the administration guidelines for Sachol, a Choline Salicylate and Cetalkonium Chloride oromucosal gel.

Administration Guidelines

Route and Form

Sachol is a gel intended for topical application exclusively to the oral mucosa (lining of the mouth). The product is for external oral use only and must not be swallowed.

Dosing Schedule and Frequency

Population Single Dose Frequency Constraint
Adults and Children aged 16+ Approximately 1 cm of gel. Not more than once every 3 hours.
Children (aged 4 months and over) Approximately a pea-sized amount or 0.5 cm of gel. Not more than once every 3 hours or six doses in a 24-hour period.

Procedural Steps

  1. Hand Hygiene: Wash hands before application.
  2. Application: Using a clean finger, gently massage the measured dose of gel directly onto the affected sore area of the mouth.
  3. Denture Use: If irritation is due to dentures, apply the gel and wait at least 30 minutes before re-inserting the dentures. Do not apply the product directly to the dentures.
  4. Post-Application: To ensure the gel remains effective, avoid consuming any food or drink for approximately 30 minutes after use.

Age-Group Restriction

Sachol is not suitable for infants under four months of age. The maximum dose and frequency must not be exceeded, especially in children and adolescents under 16 years, in accordance with warnings regarding salicylate-containing products.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sachol


Evidence for Use in Mouth Ulcers and Erosions

Research has studied Sachol for its use in individuals experiencing common mouth ulcers (aphthous ulcers) and small sores or breaks in the lining of the mouth, which are conditions associated with acute or disruptive episodes of pain. The available studies, which include both clinical trials and observational research, research examined whether outcomes related to physical discomfort evolve during short periods of use.

The clinical research often focused on patient-reported outcomes describing perceived discomfort. The findings describe patterns observed in the studies where, for some individuals, the application of the product, data show patterns related to physical discomfort were observed in some individuals. Trials assessing short-term or episodic symptom patterns often provide insights into immediate local changes.

However, the evidence quality varies across studies, and research into the specific ways the product may be related to changes in discomfort remains ongoing. Comparative evidence is lacking for many aspects, meaning it is not fully established how the observed changes compare to other products or to healing without treatment. Therefore, the degree to which individual responses may vary is a subject where more research is needed.


Evidence for Use in Gum Inflammation (Gingivitis)

Sachol was evaluated in research settings involving mild to moderate gum inflammation (gingivitis), a condition marked by functional limitations and outcomes linked to inflammatory or irritative states in the gum tissue. These studies primarily focused on local application and monitored temporary changes in gum appearance and patient-reported outcomes describing perceived discomfort.

Studies applied in research contexts involving fluctuating or unstable symptoms of gingivitis suggest that local use may be related to changes in the level of gum irritation observed in the study populations. The research describes the temporary changes in symptoms observed in the study. These findings help contextualize how patients reported their experience during the defined period of the research.


Long-term Studies and Follow-up

Research has explored the long-term patterns associated with the use of Sachol, focusing on outcomes related to systemic or functional imbalance that may arise from extended use. The available research describes what happens when the product is used over an extended period, but the data are still emerging regarding its long-term effects. The evidence is limited when it comes to consistently tracking outcomes over many months or years.


Evidence in Special Populations

Specific research has examined the use of Sachol in various special populations, including older adults and people with co-existing health conditions. For some groups, such as children or pregnant or breastfeeding individuals, the data for certain groups remain insufficient. This means that there is a significant lack of dedicated research to fully understand how Sachol might be related to outcomes for these populations.


What is Still Uncertain About Sachol

This section summarizes the main areas where research remains incomplete or where the findings were mixed. Comparative evidence is lacking in many contexts. Furthermore, research needs to provide more detail on how Sachol relates to outcomes for people with different types of underlying conditions. Finally, while studies report how symptoms evolved in the observed populations, the sample sizes were modest in some key trials. This means that data are still emerging regarding the full range of individual responses.

Key Studies & References

  1. Clinical Efficacy of a Topical Gel for the Treatment of Minor Oral Ulcers: A Triple-Blind Randomized Controlled Trial (Example RCT, Choline Salicylate component)
  2. Summary of Product Characteristics (SmPC) for Choline Salicylate/Cetalkonium Chloride Oral Gel (Regulatory Document, Safety and Special Populations)
  3. Chronic use of teething gel causing salicylate toxicity (Case Report for Special Populations/Toxicity Context)

Frequently Asked Questions (FAQ)

Common questions about Sachol (FAQ)


Q: Why does Sachol sting or burn sometimes when I first apply it?

According to regulatory documents, a transient (temporary) local burning sensation or irritation is classified as a common and expected side effect. This sensation may be related to the characteristics of the active ingredients, such as choline salicylate, and other components like alcohol (ethanol) in the gel, particularly when the gel is applied to tissue that is already damaged or inflamed.


Q: I swallowed a small amount of Sachol by accident, is that dangerous?

Sachol gel is only intended for application to the oral mucosa and should not be swallowed. Official information on the active component, choline salicylate, suggests that the accidental ingestion of a very small amount is unlikely to cause serious systemic poisoning. However, if you swallow a larger quantity or if symptoms of potential toxicity, such as ringing in the ears, begin to develop, it is advisable to consult a healthcare professional.


Q: Does Sachol have a distinct smell or taste that I should know about?

Yes, the product’s official formulation includes fragrances and excipients (non-active ingredients), often including components that provide a star anise flavor. These components are added to ensure the product has a specific, noticeable smell and taste when it is applied to the mouth.


Q: Is it normal to feel a temporary numbness in the tongue after applying Sachol?

The active ingredient, choline salicylate, is an analgesic (pain reliever) intended to reduce pain signals locally. While tongue numbness is not officially listed as a common adverse reaction, a localized change in sensation near the application site may relate to the intended pain-relieving effect (analgesia) of the medication as it begins to work.


Q: Why do some people confuse Sachol with aspirin?

People may confuse Sachol with aspirin because its primary active ingredient, choline salicylate, is a salt of salicylic acid. This compound belongs to the same family of medicines as acetylsalicylic acid (Aspirin). Regulatory labels often include a specific caution against using Sachol concurrently with aspirin or other salicylates to prevent the risk of cumulative systemic effects.


Q: Why is the active ingredient often used in teething remedies?

The active ingredient, choline salicylate, is a salicylate with established analgesic and anti-inflammatory properties. This dual action is why it has historically been used in some regions to address the discomfort associated with irritation, such such as infant teething. However, specific regulatory restrictions now apply to its use in children.


Q: Can Sachol be used for mouth pain caused by a hot drink burn?

The therapeutic purpose of Sachol is the symptomatic relief of general oral discomfort and local irritation. While a burn is not a listed indication, the gel's analgesic and anti-inflammatory actions are consistent with relieving the pain and swelling associated with general oral irritations, such as those caused by a mild thermal burn.


Q: Why is Sachol not recommended for use over long periods?

Official regulatory warnings advise against prolonged or excessive use of the gel. This restriction is primarily because extended use increases the potential for systemic adverse effects due to the absorption of the salicylate component into the bloodstream. It may also lead to localized mucosal damage at the site of application.


Q: What distinguishes Sachol's action from a simple barrier paste?

Sachol is a combination product that offers an active pharmacological effect, setting it apart from a purely physical barrier. It contains choline salicylate, which actively inhibits inflammation and pain signaling locally, and cetalkonium chloride, which has an antiseptic action. A simple barrier paste works only by providing physical protection.


Q: Are there any reported serious side effects of Sachol, and what are they?

The most serious theoretical risk highlighted in the regulatory label is the potential for Reye's syndrome in children and adolescents recovering from a viral illness (like influenza or chickenpox). Salicylate poisoning (toxicity) is also a documented risk associated with exceeding the recommended dose, which can lead to severe central nervous system symptoms.


Q: What research is available about the long-term safety of using Sachol?

Regulatory documents and research summaries indicate that data are still emerging regarding the effects and safety profile of Sachol when used over very long periods. As safety data for prolonged application are limited, the product is not recommended for extended use by official guidelines.


Q: Does alcohol consumption interact with the use of Sachol?

The gel contains a small, negligible amount of ethanol (alcohol) as an inactive ingredient. There are no specific warnings in regulatory documents regarding a direct interaction with the consumption of alcoholic beverages. However, consulting a healthcare professional is necessary to address any specific concerns.


Q: Can Sachol be used for fungal infections in the mouth (like thrush)?

Sachol contains cetalkonium chloride, which is an antiseptic agent used to help modulate the local microbial environment. While this compound possesses general antiseptic properties, the product is not specifically indicated or classified as an antifungal drug for the primary treatment of oral fungal infections, such as thrush.

How should Sachol be stored and disposed of?

Storage and Disposal of Sachol Dental Gel

Official regulatory labeling dictates specific conditions to maintain the stability and safety of Sachol dental gel.


Storage Requirements

Scope Element Regulatory Requirement
Temperature Restriction Store at a temperature below 25°C and do not freeze the medicine.
Stability After Opening Use the medicine within 6 months after first opening.
Child Protection Keep out of the sight and reach of children.
Expiration Date Do not use the medicine after the expiry date stated on the packaging.

Disposal Instructions

Patients are instructed to not dispose of the gel via wastewater or household waste. Unused or expired product should be handled as pharmaceutical waste; therefore, individuals must ask the pharmacist how to dispose of the medicine when it is no longer required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sachol found in:

A-Z Index: